Making Cancer Less Deadly Through Widely Accessible Early Detection

DELFI unleashes the power of machine learning and next-generation liquid biopsies to detect cancer in a whole new way.

Longer, Cancer-Free Lives

DELFI’s technology was developed to help people live longer, healthier, cancer-free lives by detecting cancer early—when it’s asymptomatic but easier to cure.

Widely Available Screening

Effective cancer screening requires a test accessible to everyone who needs one. DELFI’s machine learning tools work with commonly used lab methods and instruments, making early-stage cancer screening affordable and feasible for large populations. 

High-Performance Technology

DELFI’s machine learning system analyzes far more molecular data than conventional methods, deriving deeper clinical insights. 

Serving Unmet Medical Needs

Millions of high-risk individuals are not getting screened for cancer due to access and cost. A blood-based cancer screening test is easy to incorporate into routine clinical practice, with the potential to impact populations around the world.

Our Science

Join Our Team

We’re growing rapidly across all of our teams. Find your next role at DELFI.

Join Us